The event takes place from 28/10/2015 to 29/10/2015
IMA: pharmaceutical innovation at Palazzo di Varignana
This two–day event will be attended by numerous pharmaceutical customers of the IMA Group from all over the world. Our guests will have the chance to discover Prexima, the new series of tablet press machines manufactured by IMA Active division. Designed with Italian style and engineered to provide high-level performance, Prexima is equipped with the new XIMA HMI, recently awarded the A’ Design Award 2015 for its ease of use and strategic role in improving operators’ efficiency.
The new Prexima will be unveiled during the course of the evening which will take place on 28 October at the Palazzo di Varignana. The programme of the Open House includes technical presentations on IMA’s latest pharmaceutical process innovations and visits to the Group’s plants in Ozzano dell’Emilia, where the guests will be able to exchange opinions and information with our technicians: genuine added value to their daily experience in the production departments of pharmaceutical multinational corporations and companies.
IMA’s commitment to technological innovation has always given it a strong competitive advantage: constant hefty investment in R&D (approximately 5% of consolidated revenues) underlies the Group’s expansion and its ability to create value. Suffice to say that the IMA Group owns 1,300 patents and applications for patent in the world; it has more than 500 designers involved in product innovation and has launched many new machine models over the last years.
The event will be attended by Alberto Vacchi, IMA’s Chairman and CEO, who states:
“We are delighted to be hosting numerous customers from all over the world in the elegant Palazzo di Varignana and at the Group’s plants, emphasising the importance of our local territory. It will be an opportunity to enhance the innovative capacity of our Group. IMA has grown thanks to acquisitions, but it has always remained deeply rooted to its territory. IMA looks out to the world with its brain, but its heart remains in Bologna – and this is a key value.”